Radiofrequency ablation, also called rhizotomy, is a nonsurgical, minimally invasive procedure that uses heat to reduce or stop the transmission of pain. Radiofrequency waves ablate, or “burn,” the nerve that is causing the pain, essentially eliminating the transmission of pain signals to the brain.
This procedure is most commonly used to treat chronic pain and conditions such as arthritis of the spine (spondylosis) and sacroilitis. It is also used to treat neck, back, knee, pelvic and peripheral nerve pain.
The benefits of radiofrequency ablation include: avoiding surgery, immediate pain relief, little to no recovery time, decreased need for pain medication, improved function, and a quicker return to work and other activities.
The principals of Diros Technology Inc. have been at the forefront of Radiofrequency (RF) for Neurosurgery and Pain Management since the establishment of the OWL® brand in 1969. Diros was founded in 1983 to continue the advancement of new and innovative RF Products.
An industry pioneer in Radiofrequency (RF) products, offering pain management technology across the globe, which is a minimally invasive method that has applications in many chronic pain conditions, such as, cervical, thoracic, lumbar, sacroiliac, knee, hip, foot pain.
RFA is recommended for patients with chronic pain who do not respond to conventional, pharmacological treatments and cannot or do not want to undergo surgery.
Who is a candidate for Diros RFA?
Radiofrequency ablation is a treatment option for patients who have experienced successful pain relief after a diagnostic nerve/pain receptor block injection.
Radiofrequency ablation is done using fluoroscopic (x-ray) guidance and should NOT be performed on people who have an infection, are pregnant, or have bleeding problems.
Who performs the procedure?
It can be used by doctors of various specialties such as Anesthesiologists, Pain Doctor, Interventional Radiologist, Neurologists, and Orthopedic Surgeons.